Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2015 September;67(3) > Minerva Urologica e Nefrologica 2015 September;67(3):201-10

CURRENT ISSUEMINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

REVIEWS  HOT TOPICS IN PROSTATE CANCER


Minerva Urologica e Nefrologica 2015 September;67(3):201-10

language: English

Magnetic resonance imaging for prostate cancer: what the urologist needs to know

Kiechle J. E. 1, Pahwa S. 2, Gulani V. 2, Kanaan G. 1, Sedelaar J. P. 3, Ponsky L. E. 1

1 Urology Institute, Case Western Reserve University, School of Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA;
2 Department of Radiology, Case Western Reserve University, School of Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA;
3 Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands


FULL TEXT  REPRINTS


The use of magnetic resonance imaging (MRI) for prostate cancer imaging has been an area of burgeoning research activity with a goal of finding imaging characteristics that will allow for improved diagnosis and surveillance of prostate cancer. This article will review the MRI sequences currently used for imaging the prostate and describe the scoring and reporting system used by radiologists for prostate MRI known as the Prostate Imaging Reporting and Data System (PI-RADS). Current research regarding the role of prostate MRI for patients without prior biopsy, with prior negative biopsy and elevated PSA, and on active surveillance protocols will also be reviewed.

top of page